E. Walter

Vitamin D supplementation in northern Native communities

Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children

Escitalopram

A new taxonomy for describing and defining adherence to medications

Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report

Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations

Beneficial Effects of Green Tea—A Review

Radiological and biochemical resolution of nutritional rickets with calcium * COMMENTARY

Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Congenital rickets.

Citalopram versus other anti-depressive agents for depression

Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats

Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis

Changes with malnutrition in the concentration of plasma vitamin D binding protein in growing rats

Industry sponsorship and research outcome

Cost-effectiveness analysis of escitalopram: a new SSRI in the first-line treatment of major depressive disorder in Austria

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria

Rickets and protein malnutrition in northern Nigeria

Guidelines zur gesundheitsökonomischen Evaluation Konsenspapier

Cost-Effectiveness of Escitalopram versus Citalopram in the Treatment of Severe Depression